Andrew Gold
Physician Assistant · Cleveland, TXNPI 1285956854
Payments from drug & device makers
Across 256 payments — averaging $17.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$914
- AstraZeneca$464
- Lilly USA, LLC$457
- AbbVie$390
- Novo Nordisk$315
- Mylan Specialty L.p.$234
- plus $2K from 24 others
What the payments were for
- Food & beverage$4,367100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 54 | $914 |
| AstraZeneca | 23 | $464 |
| Lilly USA, LLC | 32 | $457 |
| AbbVie | 26 | $390 |
| Novo Nordisk | 19 | $315 |
| Mylan Specialty L.p. | 11 | $234 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 15 | $223 |
| Otsuka America Pharmaceutical, Inc. | 11 | $209 |
| Boehringer Ingelheim | 8 | $134 |
| Pfizer | 7 | $109 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $103 |
| Astellas Pharma US Inc | 5 | $99 |
| Lundbeck LLC | 4 | $87 |
| Sunovion Pharmaceuticals Inc. | 7 | $85 |
| Sanofi-aventis U.S. LLC | 6 | $85 |
| Xeris Pharmaceuticals, Inc. | 4 | $78 |
| Sumitomo Pharma America, Inc. | 3 | $64 |
| Alnylam Pharmaceuticals Inc. | 2 | $49 |
| Abbott | 2 | $43 |
| Amgen | 2 | $32 |
| Bayer | 2 | $32 |
| Tactile Systems Technology Inc | 1 | $31 |
| Viatris Specialty LLC | 1 | $25 |
| Sun Pharmaceutical Industries Inc. | 1 | $17 |
| Biogen | 1 | $17 |
| Exact Sciences | 1 | $16 |
| Amarin Pharma, Inc. | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
| Genentech USA, Inc. | 1 | $12 |
| Johnson & Johnson | 1 | $12 |
How this compares
$4,367 in reported general payments places this provider in the 85th percentile of 8,308 physician assistant providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 163 | $163,898 |
| OzempicSemaglutide | 77 | $76,301 |
| XifaxanRifaximin | 22 | $52,717 |
| IngrezzaValbenazine Tosylate | 13 | $48,588 |
| EliquisApixaban | 62 | $45,897 |
| GemtesaVibegron | 168 | $41,502 |
| FarxigaDapagliflozin Propanediol | 44 | $37,242 |
| TrulicityDulaglutide | 27 | $23,245 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 27 | $22,949 |
| JardianceEmpagliflozin | 29 | $18,811 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 18 | $11,306 |
| JanuviaSitagliptin Phosphate | 20 | $8,491 |
| TradjentaLinagliptin | 13 | $6,832 |
| Levothyroxine Sodium | 313 | $3,087 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 91 | $2,767 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $457 | $187,143190 claims |
| Novo NordiskOzempic | $315 | $76,30177 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan | $223 | $52,71722 claims |
| PfizerEliquis | $109 | $45,89762 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $64 | $41,502168 claims |
| AstraZenecaFarxiga | $464 | $37,24244 claims |
| Boehringer IngelheimJardiance, Tradjenta | $134 | $25,64342 claims |
| GSKTrelegy Ellipta | $914 | $22,94927 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 8,308 physician assistant providers in Texas.
Other physician assistant in Cleveland
- Cynthia TrickettDallas$1.3M
- Kristine KuceraMelissa$797K
- Selina SantosAustin$543K
- Matthew BrunoMcKinney$538K
- Anthony DerenciusSan Antonio$507K
- Brooke HodnickSouthlake$479K
- Holly GloverArlington$418K
- Kirk GautierAthens$416K
- Jaime RomanPlano$338K
- Michael WhiteDallas$276K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.